News and Press Releases
Dr William G Kaelin Jr joins IQVIA Board of Directors
North Carolina, US — IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of Dr William G Kaelin Jr to its board...
Category:
Posted: November 11, 2025
EpiCypher Launches Fiber-seq Kit to Democratize Single-Molecule Chromatin Mapping
11 November 2025 -- North Carolina, US -- EpiCypher, a leader in chromatin biology and epigenetics, today announced the launch of its CUTANA Fiber-seq Kit and the exclusive licensing of...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: November 11, 2025
uMotif Harnesses AI to Deliver Faster, Higher-Quality Clinical Trials with MotifAI Assistant
Boston, US, and London, UK – November 3, 2025 – uMotif – one of the clinical technology market’s fastest-growing companies – today announced a multi-phase deployment of MotifAI Assistant, its AI-driven automation, across...
Category:
Posted: November 11, 2025
Commit Biologics achieves proof-of-concept for novel Complement Engager platform in non-human primates
Novel approach harnessing the power of the complement system to drive potent cell depletion Single-dose study shows rapid and sustained immune cell depletion in blood and tissues with a very...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 11, 2025
New collaborative strategy platform launches to empower biopharma teams to reach peak sales faster and with greater confidence
11 November 2025 -- London, UK -- In a drug development landscape defined by shifting policies, geopolitical uncertainty, and increasing competitive pressure, a new collaborative strategy platform, Nmblr, has launched to empower...
Category: Biotechnology, Drug Discovery, Logistics, Other, Pharmaceutical
Posted: November 11, 2025
Inside information made public: Nanoform Granted European Commercial cGMP Manufacturing License
Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, today announced that it has received a Commercial cGMP Manufacturing License from FIMEA (Finnish Medicines Agency) for the production...
Category:
Posted: November 11, 2025
Shift Bioscience publishes improved metric calibration framework for robust genetic perturbation modeling using AI Virtual Cells
Cambridge, UK, 11 November 2025: Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of...
Category:
Posted: November 11, 2025
Shift Bioscience Ltd The Gurdon Institute Tennis Court Road Cambridge CB2 1QN United Kingdom
Synthego Launches High-Performance Molecular Reagents for Clinical and Molecular Diagnostics
10 November 2025 -- California, US -- Synthego, a leading provider of CRISPR solutions, has announced a strategic expansion of its product offerings with the launch of a new portfolio of...
Category: Biotechnology, Other, Pharmaceutical
Posted: November 10, 2025
ACG wins Red Dot Design Award for Personalised Medicine Concept
ACG, the world’s most integrated provider of solid-dosage solutions, is proud to announce that its Personalised Medicine Concept (PMC) has been awarded the prestigious Red Dot Award for high design...
Category:
Posted: November 6, 2025
Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma
Evidence of clinical activity observed in Cohort 8, including stringent complete remission in two patients from Cohort 8 HDP-101 continues to demonstrate a favorable safety profile with no dose-limiting toxicities...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 6, 2025
H&T Presspart acquires majority stake in Plas-Tech Engineering
Düsseldorf, Germany, 4th November 2025 — H&T Presspart, a division of the Heitkamp & Thumann Group, has reached agreement to acquire a majority stake in Plas-Tech Engineering, a privately-owned medical device...
Category:
Posted: November 5, 2025
Presspart Manufacturing Ltd. Whitebirk Industrial Estate Blackburn, Lancashire BB1 5RF, England
Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate
Immune response successfully improved with second generation vaccine candidate4 November 2025 -- Saint-Herblain, France -- Valneva SE, a specialty vaccine company, today announced positive results of its Phase 1 clinical...
Category: BioManufacturing, Biotechnology, Clinical Trials, Drug Delivery, Other, Pharmaceutical
Posted: November 4, 2025
Fast, precise, efficient: The freeze-drying revolution
Holzkirchen, 23 October 2025 – Tempris, the innovation leader in wireless in-process product temperature control for freeze-drying, is delighted to announce that it has been presented with the 2025 ISPE...
Category:
Posted: November 4, 2025
Wakam and the FondaMental Foundation create the Precision Mind Award to support Franco-British research on biomarkers in psychiatry
4 November 2025 -- Paris, France -- Following the signing of the Franco-British consortium agreement on biomarkers in psychiatry at the French Embassy in London on 27th October 2025, Wakam...
Category: Drug Discovery, Other, Pharmaceutical
Posted: November 4, 2025
Hôpital Albert Chenevier, Pôle de Psychiatrie 40, rue de Mesly 94000 Créteil, France
Moulded fibre instead of plastic
Sustainability and functionality are not mutually exclusive when it comes to pharmaceutical packaging. A new solution made of moulded fibre shows how both can work together: Harvest Packaging manufactures moulded...
Category:
Posted: November 4, 2025
